259 related articles for article (PubMed ID: 32930809)
21. Molecular and Cellular Bases of Lipodystrophy Syndromes.
Zammouri J; Vatier C; Capel E; Auclair M; Storey-London C; Bismuth E; Mosbah H; Donadille B; Janmaat S; Fève B; Jéru I; Vigouroux C
Front Endocrinol (Lausanne); 2021; 12():803189. PubMed ID: 35046902
[TBL] [Abstract][Full Text] [Related]
22. How to diagnose a lipodystrophy syndrome.
Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
[TBL] [Abstract][Full Text] [Related]
23. Lipodystrophy syndromes.
Herranz P; de Lucas R; Pérez-España L; Mayor M
Dermatol Clin; 2008 Oct; 26(4):569-78, ix. PubMed ID: 18793991
[TBL] [Abstract][Full Text] [Related]
24. Generalized lipoatrophy syndromes.
Sorkina E; Chichkova V
Presse Med; 2021 Nov; 50(3):104075. PubMed ID: 34562560
[TBL] [Abstract][Full Text] [Related]
25. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.
Nolis T
J Hum Genet; 2014 Jan; 59(1):16-23. PubMed ID: 24152769
[TBL] [Abstract][Full Text] [Related]
26. Lipodystrophy Syndromes.
Hussain I; Garg A
Endocrinol Metab Clin North Am; 2016 Dec; 45(4):783-797. PubMed ID: 27823605
[TBL] [Abstract][Full Text] [Related]
27. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
28. Complications of lipodystrophy syndromes.
Akinci G; Celik M; Akinci B
Presse Med; 2021 Nov; 50(3):104085. PubMed ID: 34728268
[TBL] [Abstract][Full Text] [Related]
29. Congenital lipodystrophies and dyslipidemias.
Prieur X; Le May C; Magré J; Cariou B
Curr Atheroscler Rep; 2014 Sep; 16(9):437. PubMed ID: 25047893
[TBL] [Abstract][Full Text] [Related]
30. Central players in inherited lipodystrophies.
Jeninga EH; Kalkhoven E
Trends Endocrinol Metab; 2010 Oct; 21(10):581-8. PubMed ID: 20621503
[TBL] [Abstract][Full Text] [Related]
31. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
[TBL] [Abstract][Full Text] [Related]
32. Lipodystrophy: lessons in lipid and energy metabolism.
Simha V; Garg A
Curr Opin Lipidol; 2006 Apr; 17(2):162-9. PubMed ID: 16531753
[TBL] [Abstract][Full Text] [Related]
33. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice.
Abulizi A; Perry RJ; Camporez JPG; Jurczak MJ; Petersen KF; Aspichueta P; Shulman GI
FASEB J; 2017 Jul; 31(7):2916-2924. PubMed ID: 28330852
[TBL] [Abstract][Full Text] [Related]
34. Autoimmunity in lipodystrophy syndromes.
Ceccarini G; Magno S; Gilio D; Pelosini C; Santini F
Presse Med; 2021 Nov; 50(3):104073. PubMed ID: 34547374
[TBL] [Abstract][Full Text] [Related]
35. Lipoatrophy revisited.
Reitman ML; Arioglu E; Gavrilova O; Taylor SI
Trends Endocrinol Metab; 2000 Dec; 11(10):410-6. PubMed ID: 11091118
[TBL] [Abstract][Full Text] [Related]
36. PPARγ Gene as a Possible Link between Acquired and Congenital Lipodystrophy and its Modulation by Dietary Fatty Acids.
Rodríguez-García C; Sánchez-Quesada C; Martínez-Ramírez MJ; Gaforio JJ
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432429
[TBL] [Abstract][Full Text] [Related]
37. Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype.
Strickland LR; Guo F; Lok K; Garvey WT
Diabetes Care; 2013 Aug; 36(8):2247-53. PubMed ID: 23423695
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of genetic lipodystrophies.
Bhayana S; Hegele RA
Clin Biochem; 2002 May; 35(3):171-7. PubMed ID: 12074822
[TBL] [Abstract][Full Text] [Related]
39. Severe insulin resistance syndromes.
Angelidi AM; Filippaios A; Mantzoros CS
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586681
[TBL] [Abstract][Full Text] [Related]
40. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
Bingham A; Mamyrova G; Rother KI; Oral E; Cochran E; Premkumar A; Kleiner D; James-Newton L; Targoff IN; Pandey JP; Carrick DM; Sebring N; O'Hanlon TP; Ruiz-Hidalgo M; Turner M; Gordon LB; Laborda J; Bauer SR; Blackshear PJ; Imundo L; Miller FW; Rider LG;
Medicine (Baltimore); 2008 Mar; 87(2):70-86. PubMed ID: 18344805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
